The diagnostics portfolio was expanded with ... Some of its current pipeline highlights include: Abbott Laboratories began its 125th year with approximately $22 billion in revenues and ...

Becton Dickinson surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its drug-delivery devices. Becton Dickinson beats quarterly estimates on ...

With a market cap of $202.2 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare company.

They’re at the center of a legal battle with the makers of specialized formulas for preterm infants — north suburban-based ...

Abbott Laboratories maintains a fortress-like balance ... Reported sales for the Diagnostics segment declined by 1.5% year-over-year (and grew by 3.3% organically) to $2.4 billion for the third ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. Financial Insights: Abbott Laboratories Market Capitalization ...

Diversified Product Portfolio: Abbott Laboratories' diverse range of medical devices, diagnostic testing products, nutritional products, and branded generic pharmaceuticals is a significant strength.

Abbott Laboratories showcases robust financial performance with a notable increase in net earnings. Strategic acquisitions ...

we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other pharma stocks. Healthcare takes ...

Welcome to Abbott's Third Quarter 2024 Earnings Conference ... low sugar to help people optimize their health and wellness. Moving to Diagnostics. Our sales in Core Laboratory Diagnostics ...